These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5870956)

  • 1. [Treatment of middle-aged and elderly arteriosclerosis patients with "Tsetamifen" (Feneksol)].
    Shvidchenko LG
    Vrach Delo; 1965 Aug; 8():117-8. PubMed ID: 5870956
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use in geriatrics of a preparation with antisclerotic action. (Preliminary results)].
    Solaro F; Corletto F; Dinale M
    G Gerontol; 1969 Aug; 17(8):801-7. PubMed ID: 5371743
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of cetamiphen in patients with coronary arteriosclerosis].
    Savenkov PM
    Sov Med; 1966 Apr; 29(4):98-100. PubMed ID: 5984051
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary studies on indobufen (K 3920). A new inhibitor of platelet aggregation.
    Gürsoy AZ; Yardimci TU; Emekli NB; Ugur MS; Ulutin ON
    Haematologica; 1981 Dec; 66(6):756-67. PubMed ID: 6802717
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative evaluation of the hypolipidemic effect of cetamiphen, polysponin and miscleron in middle-aged and elderly patients with hypertension].
    Chaialo PP; Tokar' AV; Rudaia ES
    Vrach Delo; 1980 Nov; (11):52-3. PubMed ID: 7467262
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical study of a spasmolytic agent (cyclospasmol) in the treatment of elderly arteriosclerotic patients.
    Ward PJ
    Ulster Med J; 1965 Dec; 34(2):129-36. PubMed ID: 5326929
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term trial (6 months) of the platelet aggregation inhibitory activity and biological safety of indobufen in cerebrovascular patients.
    Mansi D; Majello L; Palma V; De Michele G; Buscaino GA
    Acta Neurol (Napoli); 1983 Dec; 5(6):447-55. PubMed ID: 6367383
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of treatment with indobufen on blood viscosity indices and exercise tolerance in patients with coronary disease].
    Rdzanek H; Kochmański M; Zochowski RJ
    Wiad Lek; 1993 Apr; 46(7-8):245-9. PubMed ID: 8249409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term clinico-biological study of a platelet anti-aggregant (triflusal) in patients with progressive arteriosclerosis].
    de la Torre AG; Pacho J; Estevan JM; Valle A; Olay JR; Díez O; Alvarez J; Adeba E; Alonso R
    Angiologia; 1984; 36(6):279-82. PubMed ID: 6517386
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of atherosclerotic patients with eleuthera bark extract].
    Golikov AP
    Voen Med Zh; 1966 Sep; 9():24-7. PubMed ID: 5993957
    [No Abstract]   [Full Text] [Related]  

  • 11. A single-blind cross-over comparison of fenbufen 600 mg nocte and piroxicam 20 mg nocte in osteoarthritis.
    Wade AG
    Eur J Rheumatol Inflamm; 1981; 4(3):357-63. PubMed ID: 6242958
    [No Abstract]   [Full Text] [Related]  

  • 12. [L-triiodothyronine in the prevention and therapy of arteriosclerosis].
    Pompei A; Traverso E; Ronzitti M
    Arch Maragliano Patol Clin; 1969; 25(6):519-36. PubMed ID: 5409098
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of a myoleptic treatment in arterial disease].
    Lesbre FS; Deu J; Canicave JC
    Lyon Med; 1972 Sep; 228(14):209-10. PubMed ID: 5082770
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolic and circulatory effects of "Complamin" in arteriosclerosis patients].
    DuRuisseau JP; Laurendeau E
    Union Med Can; 1966 Oct; 95(10):1171-7. PubMed ID: 5920068
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of pyridinol carbamate treatment of coronary atherosclerosis].
    Aguirre LV; Eseverri JL; Fajardo D; Ciliberti E; Quijano E; Lucerelli R
    Prensa Med Argent; 1970 Jun; 57(16):778-83. PubMed ID: 5457375
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating platelet aggregates in cerebrovascular diseases. Preliminary data.
    Carrieri P; La Pia S; Indaco A; Pisano P; Orefice G; Iadevaia V
    Acta Neurol (Napoli); 1981 Jun; 3(3):500-4. PubMed ID: 7282470
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous heparin anticoagulation in patients with arteriosclerosis and arterial emboli.
    Campbell HC; Hubbard SG; Ernst CB
    Surg Gynecol Obstet; 1980 Jan; 150(1):54-6. PubMed ID: 7350702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of peripheral arteriosclerotic circulation disorders with sex hormones].
    Meng W; Meng S
    Z Arztl Fortbild (Jena); 1968 Dec; 62(24):1306-9. PubMed ID: 5714204
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A; Tascino C; Costa F
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of a single dose of cinnarizine on the peripheral flow and renogram of arteriosclerotic patients].
    Indovina I; Salerno L; Custro N
    Minerva Cardioangiol; 1980 May; 28(5):355-8. PubMed ID: 7207825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.